Jenscare Scientific Co., Ltd. (HKG:9877)

Jenscare Scientific Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Selling, General & Admin	94.17	68.18	150.31	219.7	238.51	131.48
Research & Development	149.29	142.64	288.15	291.58	265.34	170.63
Operating Expenses	243.46	210.82	438.46	511.28	503.84	302.11
Operating Income	-231.63	-210.82	-438.46	-511.28	-503.84	-302.11
Interest Expense	-0.29	-0.29	-0.14	-0.11	-0.13	-0.59
Interest & Investment Income	10.78	11.25	19.33	8.36	1.77	0.13
Earnings From Equity Investments	-	-	18.95	16.17	1.34	-
Currency Exchange Gain (Loss)	-6.54	2.91	3.17	34.62	-6.84	-
Other Non Operating Income (Expenses)	-22.99	7.06	18.24	10.62	0.54	1.4
EBT Excluding Unusual Items	-250.67	-189.89	-378.92	-441.62	-507.16	-301.18
Gain (Loss) on Sale of Investments	7.07	10.84	-0.17	0.72	6.49	1.5
Gain (Loss) on Sale of Assets	-0.06	-0.09	-0.01	-0.01	-	-
Asset Writedown	-6.69	-6.69	-	-	-	-
Pretax Income	-250.35	-185.83	-379.1	-440.91	-500.67	-299.67
Earnings From Continuing Operations	-250.35	-185.83	-379.1	-440.91	-500.67	-299.67
Minority Interest in Earnings	5.54	8.32	7.36	1.6	0.16	0.23
Net Income	-244.81	-177.51	-371.74	-439.31	-500.52	-299.45
Net Income to Common	-244.81	-177.51	-371.74	-439.31	-500.52	-299.45
Shares Outstanding (Basic)	407	409	417	365	338	279
Shares Outstanding (Diluted)	407	409	417	365	338	279
Shares Change (YoY)	-1.97%	-1.97%	14.17%	7.96%	21.43%	-
EPS (Basic)	-0.60	-0.43	-0.89	-1.20	-1.48	-1.07
EPS (Diluted)	-0.60	-0.43	-0.89	-1.20	-1.48	-1.07
Free Cash Flow	-258.68	-288.81	-300.64	-180.14	-155.17	-48.95
Free Cash Flow Per Share	-0.64	-0.71	-0.72	-0.49	-0.46	-0.18
EBITDA	-223.28	-201.62	-429.68	-504.82	-500.44	-299.66
D&A For EBITDA	8.35	9.2	8.78	6.46	3.41	2.44
EBIT	-231.63	-210.82	-438.46	-511.28	-503.84	-302.11

Source: S&P Global Market Intelligence. Standard template. Financial Sources.